NUWE

Announcements

Nothing here yet

Daily updates

• Nuwellis reported continued commercial traction for Aquadex SmartFlow, with 31 console placements year-to-date in 2026, exceeding the full-year totals of seven of the prior ten years and contributing to 26% year-over-year U.S. revenue growth in the first half.Sep 18, 2026

FDA designations

Nothing here yet

News

• Nuwellis received a U.S. patent for a novel catheter technology designed to improve extracorporeal therapiesJul 16, 2026
• Nuwellis completed a successful FDA pre-submission 510(k) meeting for Aquadex label expansionMay 14, 2026
• Nuwellis announces new U.S. patent for advanced safety design in pediatric extracorporeal therapyJan 6, 2026
• Nuwellis announces 92% survival in children with acute kidney injury, fluid overload, or congenital kidney failure following treatment with Aquadex®Sep 30, 2025
• Nuwellis receives new US patent reinforcing Vivian™ pediatric device focused on safer, more precise ultrafiltrationSep 18, 2025